Canada's Access to Medicines Regime background (English, HTML)

View metadata and access the original English HTML file: Canada's Access to Medicines Regime background.

Format

HTML

Access

file-only

Publisher-reported update

2020-09-17

In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems.

Access original file